Bersanlimab (Anti-ICAM1 / CD54)

Bersanlimab (Anti-ICAM1 / CD54) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects. MW: 145.5 KD.
Supplier Selleck Chemicals
Product # A2464
Sku # A2464-1mg*5
Pricing 1mg*5, $1390.00
Feedback